Lv1
10 积分 2022-10-25 加入
Aldosterone and Aldosterone Modulation in Cardio-Kidney Diseases
14天前
已完结
Baxdrostat: A Novel Aldosterone Synthase Inhibitor for Treatment Resistant Hypertension
14天前
已完结
Efficacy and Safety of Baxdrostat in Uncontrolled and Resistant Hypertension
16天前
已完结
Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial
17天前
已完结
Aldosterone breakthrough from a pharmacological perspective
17天前
已完结
Cardiovascular Complications of Diabetic Kidney Disease
21天前
已完结
Primacy of the 3B Approach to Control Risk Factors for Cardiovascular Disease in Type 2 Diabetes Patients
21天前
已关闭
68Ga-FAPI-04 Positron Emission Tomography/Magnetic Resonance Imaging for Assessing Ascending Aortic Aneurysm
23天前
已完结
Real-world practice patterns and characteristics of adverse events with selexipag in Korean patients with pulmonary arterial hypertension
24天前
已完结
Setting expectations with oral selexipag: an expert consensus-based approach on best practices to initiate, dose, titrate, and manage side effects (SEs) in patients with pulmonary arterial hypertension (PAH)
24天前
已完结
皖公网安备34019202002308
